• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补骨脂二氢黄酮的代谢活性、同工酶贡献及物种差异表征,以及HeLa1A1细胞中补骨脂二氢黄酮-O-葡萄糖醛酸苷外排转运体的鉴定。

Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.

作者信息

Li Yang, Xu Chunxia, Xu Jinjin, Qin Zifei, Li Shishi, Hu Liufang, Yao Zhihong, Gonzalez Frank J, Yao Xinsheng

机构信息

College of Pharmacy, Jinan University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.

出版信息

J Pharm Pharmacol. 2020 Dec;72(12):1771-1786. doi: 10.1111/jphp.13324. Epub 2020 Jul 9.

DOI:10.1111/jphp.13324
PMID:32648321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865092/
Abstract

OBJECTIVES

Bavachin is a bioactive natural flavonoid with oestrogen-like activity. Here, we aimed to investigate its metabolic and disposal fates involving in CYPs, UGTs and efflux transporters.

METHODS

Phase I metabolism and glucuronidation were performed by human liver microsomes (HLM). Reaction phenotyping and activity correlation analysis were performed to identify the main CYP and UGT isozymes. Chemical inhibition and gene knock-down approaches were employed to explore the function of BCRP and MRPs.

KEY FINDINGS

Five phase I metabolites (M1-M5) and three glucuronides (G1-G3) were identified. The CL values for M4 and G1 by HLM were 127.99 and 1159.07 μl/min per mg, respectively. Reaction phenotyping results suggested CYP1A1 (208.85 μl/min per mg) and CYP2C9 (107.51 μl/min per mg), and UGT1A1 (697.19 μl/min per mg), UGT1A7 (535.78 μl/min per mg), UGT1A8 (247.72 μl/min per mg) and UGT1A9 (783.68 μl/min per mg) all participated in the metabolism of bavachin. In addition, activity correlation analysis also supported the results above. Furthermore, the metabolism exhibited marked species differences, and rabbits were the appropriate model animals. Moreover, MRP4 was identified as the main contributor based on chemical inhibition and gene silencing approaches.

CONCLUSIONS

CYP1A1 and CYP2C9, UGT1A1, UGT1A7, UGT1A8 and UGT1A9, and MRP4 all played important roles in the metabolism and disposition of bavachin.

摘要

目的

补骨脂二氢黄酮是一种具有雌激素样活性的生物活性天然黄酮类化合物。在此,我们旨在研究其涉及细胞色素P450酶(CYPs)、尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)和外排转运蛋白的代谢及处置命运。

方法

采用人肝微粒体(HLM)进行Ⅰ相代谢和葡萄糖醛酸化反应。通过反应表型分析和活性相关性分析来鉴定主要的CYP和UGT同工酶。采用化学抑制和基因敲低方法来探究乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白(MRPs)的功能。

主要发现

鉴定出了5种Ⅰ相代谢产物(M1 - M5)和3种葡萄糖醛酸苷(G1 - G3)。HLM对M4和G1的清除率(CL)值分别为127.99和1159.07 μl/min per mg。反应表型分析结果表明,细胞色素P450 1A1(CYP1A1,208.85 μl/min per mg)、细胞色素P450 2C9(CYP2C9,107.51 μl/min per mg)以及尿苷二磷酸葡萄糖醛酸基转移酶1A1(UGT1A1,697.19 μl/min per mg)、尿苷二磷酸葡萄糖醛酸基转移酶1A7(UGT1A7,535.78 μl/min per mg)、尿苷二磷酸葡萄糖醛酸基转移酶1A8(UGT1A8,247.72 μl/min per mg)和尿苷二磷酸葡萄糖醛酸基转移酶1A9(UGT1A9,783.68 μl/min per mg)均参与了补骨脂二氢黄酮的代谢。此外,活性相关性分析也支持上述结果。而且,该代谢表现出显著的种属差异,兔子是合适的模型动物。此外,基于化学抑制和基因沉默方法确定多药耐药相关蛋白4(MRP4)是主要贡献者。

结论

CYP1A1、CYP2C9、UGT1A1、UGT1A7、UGT1A8、UGT1A9以及MRP4在补骨脂二氢黄酮的代谢和处置过程中均发挥着重要作用。

相似文献

1
Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.补骨脂二氢黄酮的代谢活性、同工酶贡献及物种差异表征,以及HeLa1A1细胞中补骨脂二氢黄酮-O-葡萄糖醛酸苷外排转运体的鉴定。
J Pharm Pharmacol. 2020 Dec;72(12):1771-1786. doi: 10.1111/jphp.13324. Epub 2020 Jul 9.
2
Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.涉及人细胞色素 P450、UDP-葡萄糖醛酸基转移酶酶和外排转运蛋白的异甘草素代谢命运和抑制作用的潜在决定因素。
J Pharm Sci. 2021 May;110(5):2285-2294. doi: 10.1016/j.xphs.2021.02.013. Epub 2021 Feb 19.
3
Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.化学抑制和稳定敲低外排转运蛋白可减少 UGT1A1 过表达 HeLa 细胞中吴山茱萸新橙皮苷的葡萄糖醛酸化:乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白(MRPs)在葡萄糖醛酸缀合物排泄中的作用。
Food Funct. 2018 Mar 1;9(3):1410-1423. doi: 10.1039/c7fo01298e. Epub 2018 Jan 10.
4
Metabolism and disposition of corylifol A from : metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A--glucuronide in HeLa1A1 cells.来自[具体来源未给出]的蛇床子素A的代谢与处置:代谢物图谱、同工酶贡献、种属差异以及HeLa1A1细胞中蛇床子素A - 葡萄糖醛酸苷外排转运体的鉴定
Xenobiotica. 2020 Aug;50(8):997-1008. doi: 10.1080/00498254.2020.1732496. Epub 2020 Apr 1.
5
Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.鉴定尿苷二磷酸葡萄糖醛酸转移酶(UGTs)和乳腺癌耐药蛋白(BCRP)作为天然黄酮类化合物山姜素潜在的药代动力学决定因素。
Xenobiotica. 2019 Mar;49(3):276-283. doi: 10.1080/00498254.2018.1440657. Epub 2018 Feb 27.
6
An investigation of the metabolic activity, isozyme contribution, species differences and potential drug-drug interactions of PI-103, and the identification of efflux transporters for PI-103--glucuronide in HeLa1A9 cells.PI-103的代谢活性、同工酶贡献、物种差异及潜在药物相互作用的研究,以及HeLa1A9细胞中PI-103-葡萄糖醛酸苷外排转运体的鉴定。
RSC Adv. 2020 Mar 5;10(16):9610-9622. doi: 10.1039/c9ra09906a. eCollection 2020 Mar 2.
7
Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.UGT1A1 过表达 HeLa 细胞中双去甲氧基姜黄素-O-葡萄糖醛酸苷的外排排泄:鉴定乳腺癌耐药蛋白 (BCRP) 和多药耐药相关蛋白 1 (MRP1) 为葡萄糖醛酸苷转运体。
Biofactors. 2018 Nov;44(6):558-569. doi: 10.1002/biof.1452. Epub 2018 Oct 17.
8
Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.补骨脂中异补骨脂素的代谢特征及其对人细胞色素P450酶和尿苷二磷酸葡萄糖醛酸转移酶的潜在抑制作用研究
J Pharm Pharmacol. 2020 Dec;72(12):1865-1878. doi: 10.1111/jphp.13337. Epub 2020 Aug 4.
9
UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.过表达 UDP-葡糖醛酸基转移酶 1A9 的 HeLa 细胞是一种合适的工具,可用于描绘乳腺癌耐药蛋白 (BCRP) 和 UGT 之间的动力学相互作用,并快速鉴定 BCRP 的葡萄糖醛酸苷底物。
Drug Metab Dispos. 2012 Feb;40(2):336-45. doi: 10.1124/dmd.111.041467. Epub 2011 Nov 9.
10
[Study on metabolic dynamics,metabolic enzyme phenotype and species difference of hepatic and intestinal microsome of psoralidin].补骨脂定肝肠微粒体代谢动力学、代谢酶表型及种属差异研究
Zhongguo Zhong Yao Za Zhi. 2021 Jul;46(13):3410-3421. doi: 10.19540/j.cnki.cjcmm.20210305.201.

引用本文的文献

1
Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2.补骨脂素通过MFN2增强线粒体β-氧化和脂质代谢,改善顺铂诱导的肾毒性。
Mol Med. 2025 Jun 11;31(1):234. doi: 10.1186/s10020-025-01283-6.
2
Chronic disease management via modulation of cellular signaling by phytoestrogen Bavachin.通过植物雌激素紫檀芪调节细胞信号转导进行慢性病管理。
Mol Biol Rep. 2024 Aug 19;51(1):921. doi: 10.1007/s11033-024-09849-z.
3
Bavachin Rejuvenates Sensitivity of Colistin against Colistin-Resistant Gram-Negative Bacteria.荭草素恢复多黏菌素对多黏菌素耐药革兰氏阴性菌的敏感性。
Int J Mol Sci. 2024 Feb 16;25(4):2349. doi: 10.3390/ijms25042349.
4
Identification of Human UDP-Glucuronosyltransferase Involved in Gypensapogenin C Glucuronidation and Species Differences.鉴定参与吉普萨皂甙元 C 葡萄糖醛酸化的人尿苷二磷酸葡萄糖醛酸转移酶及种属差异。
Int J Mol Sci. 2023 Jan 11;24(2):1454. doi: 10.3390/ijms24021454.
5
Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens.仙灵骨葆胶囊中天然存在的雌激素葡萄糖醛酸化抑制剂的鉴定。
Front Pharmacol. 2022 Aug 4;13:935685. doi: 10.3389/fphar.2022.935685. eCollection 2022.
6
Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.天然黄酮类化合物补骨脂乙素的潜在代谢决定因素及药物相互作用
RSC Adv. 2020 Sep 23;10(58):35141-35152. doi: 10.1039/d0ra06961b. eCollection 2020 Sep 21.
7
Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism.关于荭草素与补骨脂乙素相互作用的药代动力学研究及其潜在机制。
Pharm Biol. 2021 Dec;59(1):1256-1259. doi: 10.1080/13880209.2021.1942924.
8
Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.补骨脂中异补骨脂素的代谢特征及其对人细胞色素P450酶和尿苷二磷酸葡萄糖醛酸转移酶的潜在抑制作用研究
J Pharm Pharmacol. 2020 Dec;72(12):1865-1878. doi: 10.1111/jphp.13337. Epub 2020 Aug 4.

本文引用的文献

1
Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus.药物代谢酶与中药补骨脂的相互作用。
Chin J Nat Med. 2019 Nov;17(11):858-870. doi: 10.1016/S1875-5364(19)30103-7.
2
Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system.解析草药成分的代谢命运以及草药与人体代谢系统的相互作用。
Chin J Nat Med. 2019 Nov;17(11):801-802. doi: 10.1016/S1875-5364(19)30098-6.
3
The Efflux Mechanism of Fraxetin--Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors.虎杖苷葡萄糖醛酸苷在UGT1A9转染的HeLa细胞中的外排机制:确定多药耐药相关蛋白3和4(MRP3/4)为重要贡献者
Front Pharmacol. 2019 May 7;10:496. doi: 10.3389/fphar.2019.00496. eCollection 2019.
4
Recent progress and challenges in screening and characterization of UGT1A1 inhibitors.UGT1A1抑制剂筛选与表征的最新进展及挑战
Acta Pharm Sin B. 2019 Mar;9(2):258-278. doi: 10.1016/j.apsb.2018.09.005. Epub 2018 Sep 14.
5
Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.UGT1A1 过表达 HeLa 细胞中双去甲氧基姜黄素-O-葡萄糖醛酸苷的外排排泄:鉴定乳腺癌耐药蛋白 (BCRP) 和多药耐药相关蛋白 1 (MRP1) 为葡萄糖醛酸苷转运体。
Biofactors. 2018 Nov;44(6):558-569. doi: 10.1002/biof.1452. Epub 2018 Oct 17.
6
The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells.在 UGT1A1 过表达的 HeLa 细胞中,乳腺癌耐药蛋白(BCRP/ABCG2)和多药耐药相关蛋白(MRPs/ABCCs)在环黄芪醇-3-O-葡萄糖苷排泄中的作用。
Chem Biol Interact. 2018 Dec 25;296:45-56. doi: 10.1016/j.cbi.2018.09.001. Epub 2018 Sep 17.
7
Metabolic profiling of corylin in vivo and in vitro.体内和体外辛弗林的代谢特征分析。
J Pharm Biomed Anal. 2018 Jun 5;155:157-168. doi: 10.1016/j.jpba.2018.03.047. Epub 2018 Mar 26.
8
Plasma pharmacokinetics and cerebral nuclei distribution of major constituents of Psoraleae fructus in rats after oral administration.口服补骨脂后大鼠血浆药代动力学及脑内主要成分分布
Phytomedicine. 2018 Jan 1;38:166-174. doi: 10.1016/j.phymed.2017.12.002. Epub 2017 Dec 6.
9
Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.化学抑制和稳定敲低外排转运蛋白可减少 UGT1A1 过表达 HeLa 细胞中吴山茱萸新橙皮苷的葡萄糖醛酸化:乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白(MRPs)在葡萄糖醛酸缀合物排泄中的作用。
Food Funct. 2018 Mar 1;9(3):1410-1423. doi: 10.1039/c7fo01298e. Epub 2018 Jan 10.
10
Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes.补骨脂中的补骨脂二氢黄酮通过胰岛素信号传导和激活3T3-L1脂肪细胞中的AMPK改善胰岛素依赖性葡萄糖摄取。
Int J Mol Sci. 2016 Apr 8;17(4):527. doi: 10.3390/ijms17040527.